Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Exelixis, Inc. (EXEL)

« Back to company index

EXEL Chatter Timeline

Stock Ticker for EXEL

Most Active Tweeters for EXEL

UserTweets
@dailypoliticaln 4
@ConsumerFeed 4
@TickerReport 3
@AmericanBanking 3
@reurope_stock 3

Recent Tweets for EXEL

Atip4 @Atip4
$exel ..... good stuff https://t.co/mvRqFr2LvG
July 19th 2018, 1:07pm
SADIFAnalytics @SADIFAnalytics
Will Exelixis Inc Deliver Long-Term Returns? $EXEL https://t.co/pS5rEWyDuJ
July 19th 2018, 7:07am
ThisLincolnian @ThisLincolnian
Michael Morrissey Sells 90,000 Shares of Exelixis, Inc. $EXEL Stock https://t.co/VVj3wEF1vo
July 19th 2018, 4:07am
Clover_Research @Clover_Research
I also have 2 ratings on $EXEL which will eventually come to fruition. People are thinking they'll have another beat come ER.
July 18th 2018, 4:07pm
PivotBoss @PivotBoss
[MEMBERS] PivotBoss Trading Room PM [July 18, 2018]: Add $EXEL to the Watchlist https://t.co/1kMRmElr8a #pivotboss
July 18th 2018, 4:07pm
filing_scanner @filing_scanner
$EXEL New Insider Filing On: MORRISSEY MICHAEL Transaction Code: M https://t.co/teUYgLfPCI https://t.co/qzE0Merbqa
July 18th 2018, 1:07pm
pnani456 @pnani456
$EXEL M30 rotation up / D1 50SMA tag and bounce back above 20SMA https://t.co/PaVtadxviV
July 18th 2018, 10:07am
InsiderAlertsIA @InsiderAlertsIA
$EXEL: New Insider Filing on President and CEO MICHAEL MORRISSEY: https://t.co/ctcFbjAkAv
July 18th 2018, 9:07am
ConsumerFeed @ConsumerFeed
Exelixis, Inc. $EXEL Insider Michael Morrissey Sells 90,000 Shares of Stock https://t.co/kaEDSRnOmR
July 18th 2018, 6:07am
ConsumerFeed @ConsumerFeed
Exelixis Insider Michael Morrissey Sells $1,901,700.00 in $EXEL https://t.co/KiGikx2iJH
July 18th 2018, 3:07am
ataglieri1 @ataglieri1
Insider alert: President and CEO MORRISSEY MICHAEL of $EXEL bought 90,000 shares @ $495,000.00
July 18th 2018, 2:07am
filing_scanner @filing_scanner
$EXEL New Insider Filing On: MORRISSEY MICHAEL Transaction Code: M https://t.co/teUYgLfPCI https://t.co/b0ovt37WDJ
July 17th 2018, 11:07pm
TickerReport @TickerReport
Exelixis, Inc. $EXEL Insider Michael Morrissey Sells 90,000 Shares https://t.co/VSBYm7VIDW
July 17th 2018, 10:07pm
AmericanBanking @AmericanBanking
Exelixis, Inc. $EXEL Insider Michael Morrissey Sells 90,000 Shares https://t.co/QS0qslL2g2 #stocks
July 17th 2018, 10:07pm
dailypoliticaln @dailypoliticaln
Exelixis, Inc. $EXEL Insider Sells $1,901,700.00 in Stock https://t.co/8bgEJWcOcL
July 17th 2018, 10:07pm
insiderbuyings @insiderbuyings
$EXEL new insider selling: 90000 shares. https://t.co/xjRrt8STVo
July 17th 2018, 9:07pm
StockTexts @StockTexts
$EXEL Exelixis, Inc. SEC Filing: Form 4 https://t.co/WZSZgO85J3
July 17th 2018, 8:07pm
poor_pinkus @poor_pinkus
$EXEL investors: We’ll be announcing our Q2 earnings on 8/1. Webcast details here: https://t.co/8fGb2K9s5x.
July 17th 2018, 7:07pm
poor_pinkus @poor_pinkus
@bibeypost_stock $EXEL I think they come in at $0.22 EPS
July 17th 2018, 7:07pm
bibeypost_stock @bibeypost_stock
Exelixis, Inc. $EXEL Analysts See $0.14 EPS - https://t.co/OaEdLIHHd8
July 17th 2018, 6:07pm
reurope_stock @reurope_stock
$0.14 EPS Expected for Exelixis, Inc. $EXEL https://t.co/KhM3kOjaui
July 17th 2018, 6:07pm
mmahotstuff1 @mmahotstuff1
$0.14 EPS Expected for Exelixis, Inc. $EXEL - https://t.co/v3OF8LWcO7
July 17th 2018, 6:07pm
whatsonthorold2 @whatsonthorold2
EPS for Exelixis, Inc. $EXEL Expected At $0.14 - https://t.co/GMTOGb3Pns
July 17th 2018, 6:07pm
ChartMill @ChartMill
Although the technical rating is bad, $EXEL does present a nice setup opportunity. https://t.co/eIQbqxkwIy https://t.co/drAIDFyGmM
July 17th 2018, 4:07pm
ExelixisInc @ExelixisInc
$EXEL investors: We’ll be announcing our Q2 earnings on 8/1. Webcast details here: https://t.co/cwMelmYuQW. https://t.co/I556fR1CmQ
July 17th 2018, 4:07pm
Allstocknews @Allstocknews
$EXEL Exelixis to Release Second Quarter 2018 Financial Results on Wednesday, August 1, 2018 From our Stock News Alerts App
July 17th 2018, 4:07pm
AmericanBanking @AmericanBanking
Exelixis, Inc. $EXEL Given Average Rating of “Hold” by Analysts https://t.co/trUJ2Cubn3 #stocks
July 17th 2018, 7:07am
TickerReport @TickerReport
Exelixis, Inc. $EXEL Given Average Rating of “Hold” by Analysts https://t.co/J8EexwwpG9
July 17th 2018, 7:07am
dailypoliticaln @dailypoliticaln
Exelixis, Inc. $EXEL Given Consensus Rating of “Hold” by Brokerages https://t.co/ewqwuK4ex3
July 17th 2018, 7:07am
studentoflife @studentoflife
RT @tgtxdough: RBC $EXEL looking specifically for guidance updates for Cabometyx (Cabo) given the approval of IO combo Opdivo + Yervoy in 1…
July 16th 2018, 1:07pm
tgtxdough @tgtxdough
RBC $EXEL looking specifically for guidance updates for Cabometyx (Cabo) given the approval of IO combo Opdivo + Ye… https://t.co/h0gVG2IPnd
July 16th 2018, 12:07pm
bibeypost_stock @bibeypost_stock
Were Analysts Bearish Exelixis, Inc. $EXEL This Week? - https://t.co/0XFZOMTQgE
July 15th 2018, 10:07am
reurope_stock @reurope_stock
How Many Exelixis, Inc. $EXEL's Analysts Are Bullish? https://t.co/02rY3WfNsm
July 15th 2018, 10:07am
MareaInformativ @MareaInformativ
Exelixis, Inc. $EXEL Short Interest Update https://t.co/q9z1fZrqlc
July 15th 2018, 6:07am
dailypoliticaln @dailypoliticaln
Exelixis, Inc. $EXEL Short Interest Update https://t.co/yrEgLc7bwn
July 15th 2018, 1:07am
ThisLincolnian @ThisLincolnian
Short Interest in Exelixis, Inc. $EXEL Increases By 39.2% https://t.co/EezgxITdfv
July 14th 2018, 8:07pm
ConsumerFeed @ConsumerFeed
Short Interest in Exelixis, Inc. $EXEL Increases By 39.2% https://t.co/7VTdboXUyF
July 14th 2018, 8:07pm
ResearchPool @ResearchPool
$EXEL #Exelixis Inc. Cabozantinib is approved in three indications but needs further entrenchment to dig a moat.: S… https://t.co/NhvOXTysep
July 13th 2018, 3:07pm
AmericanBanking @AmericanBanking
Exelixis, Inc. $EXEL Short Interest Up 39.2% in June https://t.co/iLPiQ8Bq91 #stocks
July 13th 2018, 2:07am
TranscriptDaily @TranscriptDaily
Exelixis, Inc. $EXEL Short Interest Up 39.2% in June https://t.co/URaneOluu9
July 13th 2018, 2:07am
TraderJoost @TraderJoost
https://t.co/sq4xVuBRcM Long $Exel through options 21 and 22 strike various exps.
July 12th 2018, 10:07am
biogemfinder @biogemfinder
$EXEL after many months finally an uptrend has started. The 20d moving average is crossing the 50d MA, given all th… https://t.co/XWWWbmGQSc
July 11th 2018, 1:07pm
ChartMill @ChartMill
$EXEL has a good Piotroski-F score of 7.00. This indicates a good health and profitability. https://t.co/ARDF3t8ptk https://t.co/MYp2be5uHW
July 11th 2018, 11:07am
jfais20 @jfais20
$EXEL Piper Jaffray says weakness is a buying opportunity, 92% of surveyed medical oncologists who treat metastatic… https://t.co/6ZLlYaVXsw
July 11th 2018, 9:07am
mmahotstuff1 @mmahotstuff1
$0.14 EPS Expected for Exelixis, Inc. $EXEL - https://t.co/KYJFX9PY8Z
July 11th 2018, 8:07am
whatsonthorold2 @whatsonthorold2
$0.14 EPS Expected for Exelixis, Inc. $EXEL - https://t.co/VoCWibdzM6
July 11th 2018, 8:07am
odibro @odibro
$EXEL Piper reiterates with an overweight. $29 PT
July 11th 2018, 5:07am
pnani456 @pnani456
$EXEL D1 long setup base breakout play https://t.co/lM5va0JTkc
July 10th 2018, 10:07am
TheMarketsDaily @TheMarketsDaily
Exelixis $EXEL versus PRA Health Sciences $PRAH Financial Comparison https://t.co/UspURnaY0Z
July 10th 2018, 10:07am
bibeypost_stock @bibeypost_stock
Exelixis Inc $EXEL: Institutional Investors Are Worried - https://t.co/LYNP4ME3Zi
July 9th 2018, 6:07am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.